Medical Device Maker Stryker Says It's Not in Talks to Buy Boston Scientific
Medical device maker Stryker is not in talks to buy rival Boston Scientific, the company said in a regulatory filing on Wednesday that CNBC News (June 13) reported on. This comes two days after a media report of a potential deal between the two made headlines. "There has been rapid consolidation across the health-care industry in recent years," CNBC observes, "but there has been a slower stream of larger deals in the medical device sector." A potential transaction involving Stryker and Boston Scientific would create a combined company with a market value of over $110 billion. "The filing from Stryker states that the company is not in discussions with Boston Scientific. It does not deny that prior discussions took place," observes Jason Benowitz, senior portfolio manager at Roosevelt Investment Group.
Abstract News © 2018 INFORMATION, INC.